Designed to improve the appearance of signs of ageing, the SkinCeuticals Tripeptide R Neck Repair Cream is carefully formulated to target both early and advanced wrinkles. It's created to be used on your neck, ensuring that this part of your body receives tailored care along with your face. Often neglected in skincare routines, your neck needs to be protected and nourished to maintain your all-over youthful illusion. Formulated using Retinol, the cream is a powerful product that works on softening the look of both fine lines and wrinkles. These can be caused by repeated actions, such as looking down towards a screen, which is increasingly common in the modern world. At a 0.2% concentration, the pure Retinol has a slow-release delivery to maximise efficacy. A 2.5% Tripeptide concentrate and 5% Glaucine complex, from the yellow poppy seed plant, work alongside each other to exert a corrective action across skin. Key Benefits: Clinically demonstrated to improve the appearance of visible neck aging, including horizontal neck lines and wrinkles, loss of firmness, crepiness, and uneven skin tone 27% average improvement in neck skin crepiness* 16% average improvement in the appearance of horizontal neck lines* 16% average improvement in neck skin firmness* Pair with Triple Lipid Restore 2:4:2 for full face and neck correction and to shorten the adjustment period to retinoids Paraben-, alcohol-, dye-, and fragrance-free Ideal as a complement to neck contouring treatments, such as under-chin cryolipolysis and skin tightening treatments. Consult your skincare professional to ensure the right treatment for you *A 16-week, clinical study was conducted on 50 females, ages 40-60, with mild to moderate sagging on neck, fine lines and wrinkles, including horizontal neck lines, firmness on neck, crepiness, elasticity on neck, rough skin, and uneven skin tone. Tripeptide-R Neck Repair was used nightly as tolerated in conjunction with a sunscreen. After 1 week, use was increased to twice daily as tolerated in conjunction with a sunscreen. Efficacy evaluations were conducted at baseline and at weeks 4, 8, 12, and 16.
